US FDA warns doctors to use cisapride as last resort only

被引：1

|

作者：

Ault, A

机构：

来源：

LANCET | 1998年 / 352卷 / 9122期

关键词：

D O I：

10.1016/S0140-6736(98)85030-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：120 / 120

页数：1

相关论文

共 50 条

[1] AVERSIVES ONLY AS A LAST RESORT
RUTTENBERG, BA
[J]. JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1978, 8 (01): : 106 - 107
[2] Should the FDA be the doctor of last resort?
DeVita, VT
[J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (09): : 423 - 423
[3] Should the FDA be the doctor of last resort?
Vincent T DeVita
[J]. Nature Clinical Practice Oncology, 2005, 2 : 423 - 423
[4] Rituxan associated with PML, warns US FDA
[J]. Reactions Weekly, 2007, 1133 (1) : 3 - 3
[5] US FDA warns of hypericum/indinavir interaction
[J]. Reactions Weekly, 2000, 789 (1) : 2 - 2
[6] US FDA warns against the use of Liqiang 4 Dietary Supplement Capsules
[J]. Reactions Weekly, 2005, 1059 (1) : 2 - 2
[7] Bariatric surgery: why only a last resort?
不详
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (02): : 91 - 91
[8] Only as a last resort - Primate experiments are justified - if scientists can tell us what they're for
不详
[J]. NEW SCIENTIST, 2002, 176 (2370) : 5 - 5
[9] US FDA warns about ibuprofen and aspirin interaction
[J]. Reactions Weekly, 2006, 1119 (1) : 2 - 2
[10] US FDA warns Pfizer over tardy pharmacovigilance
[J]. Reactions Weekly, 2010, 1306 (1) : 2 - 2

← 1 2 3 4 5 →